GlassScriptPhysician profile
Roger Corvasce
NPI 1033792999
$11,409.35
in general payments reported to CMS, 2019-2025
9 companies · $1,992 in 2025
The $1,992 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,615 · 2022: $5,013 · 2023: $219 · 2024: $570 · 2025: $1,992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,817 · Travel and Lodging: $965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,816.72 |
| Travel and Lodging | $964.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $8,489.04 | 2021-2025 | |
| Medical Device Business Services, INC. | $1,273.74 | 2024-2025 | Velys |
| Stryker Corporation | $560.18 | 2022-2025 | Mako, Aequalis Perform+, Blueprint Patient Specific Instrumentation |
| Depuy Synthes Sales INC. | $429.81 | 2024-2025 | Na, Attune, Tfn-Advance |
| Si-Bone, INC. | $218.01 | 2022-2025 | |
| Heron Therapeutics, INC. | $124.74 | 2024 | Zynrelef |
| Convatec INC. | $124.27 | 2023 | |
| Orthofix Medical, INC. | $101.72 | 2025 | Physio-Stim |
| Polynovo North America LLC | $87.84 | 2024 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Corvasce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.